Wird geladen...
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
The biology of atypical hemolytic uremic syndrome has been shown to involve inability to limit activation of the alternative complement pathway, with subsequent damage to systemic endothelial beds and the vasculature, resulting in the prototypic findings of a thrombotic microangiopathy. Central to t...
Gespeichert in:
| Veröffentlicht in: | J Blood Med |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4835139/ https://ncbi.nlm.nih.gov/pubmed/27110144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S36249 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|